Trxade Group Inc (MEDS) — Capital Reinvestment Ratio
Trxade Group Inc (MEDS) has a Capital Reinvestment Ratio of 0.16x as of June 2023, meaning it reinvests 0% of its operating cash flow ($328.57K) in capital expenditures ($51.80K). See debt-free asset ratio of Trxade Group Inc to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Trxade Group Inc Capital Reinvestment Ratio (2017–2019)
This chart tracks Trxade Group Inc's Capital Reinvestment Ratio across 3 annual periods. Check Trxade Group Inc (MEDS) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Trxade Group Inc (2017–2019)
Year-by-year Capital Reinvestment Ratio for Trxade Group Inc from 2017 to 2019. For the full cash flow conversion analysis, see Trxade Group Inc cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.58x | $141.78K | $82.25K | ▲ +957.0% |
| 2018 | 0.05x | $273.39K | $15.01K | ▼ -37.2% |
| 2017 | 0.09x | $171.67K | $15.01K | — |